"Topics in Anti-Cancer Research covers new developments in the field of cancer. Novel drugs as anticancer agents include natural and synthetic phenazirines and other anti-cancer compounds. It also encompasses the role of estrogen as estrogen disruptor and strategies targeting cancer stem cells for the treatment of different types of cancer, including myeloma and renal cell cancer.
 
The diversity of researches and topics published in this eBook Series will be valuable to our cancer researchers, clinicians, cancer professionals aiming to develop novel anti-cancer targets and patents for the treatment of various cancers.
 
The topics covered in the Eighth Volume of this series are as follows:
 
- Novel Drugs for Multiple Myeloma
 
- Synthetic Estrogens are Endocrine Disruptors via Inhibition of AF1 Domain of ERs
 
- Recent Progress of Phenazines as Anticancer Agents
 
- Cancer Stem Cell Targeting for Anticancer Therapy: Strategies and Challenges"


Topics in Anti-Cancer Research: Volume 8

End User License Agreement (for non-institutional, personal use)

2. ENDOGENOUS ESTROGENS UPREGULATE ALL PHYSIOLOGICAL FUNCTIONS OF HEALTHY CELLS, WHILE THEY INDUCE APOPTOTIC DEATH IN TUMOR CELLS

3. MOLECULAR MECHANISM OF ESTROGEN INDUCED SELF REGULATED DEATH IN CANCER CELLS

4. MOLECULAR MECHANISMS OF THE INHIBITION AND COMPENSATORY UPREGULATION OF ER SIGNALING BY SYNTHETIC ESTROGEN TREATMENT

5. BOTH SYNTHETIC ESTROGENS AND ANTIESTROGENS DEREGULATE THE BALANCE OF LIGANDED AND UNLIGANDED ACTIVATIONS OF ERS LEADING TO AN ENDOCRINE DISRUPTION

6. RECENT PATENTS SUGGEST NEW METHODS FOR IDENTIFYING ESR1 GENE AMPLIFICATION IN HUMAN CANCER SAMPLES

7. INTRODUCTION OF HIGH DOSE SYNTHETIC ESTROGEN THERAPY FOR ADVANCED BREAST CANCER IN THE PAST

8. REVISITED USE OF HIGH DOSE SYNTHETIC ESTROGEN TREATMENT AGAINST ANTIESTROGEN RESISTANT BREAST CANCERS FROM THE 1990’s

9. ADVERSE EFFECTS OF ETHINYLESTRADIOL USED AS A CONTRACEPTIVE PILL IN MEDICAL PRACTICE

10. SLIGHTLY INCREASED OVERALL BREAST CANCER RISK AMONG OC USERS

11. DECREASED RISK FOR ENDOMETRIAL AND OVARIAN CANCERS AMONG OC USERS

12. DECREASED RISK OF COLORECTAL CANCER AMONG OC USERS

13. INCREASED CERVICAL CANCER RISK AMONG OC USERS

14. USE OF MISCELLANEOUS NATURAL AND SYNTHETIC HORMONES AS A MENOPAUSAL HORMONE REPLACEMENT THERAPY

Synthetic Estrogens Deregulate Estrogen Receptors Inducing Thromboembolic Complications and Cancer

2. ANTICANCER EFFECTS OF PHENAZINES IN NON PATENT LITERATURE

3. ANTICANCER EFFECTS OF PHENAZINES IN PATENT LITERATURE

Recent Progress of Phenazines as Anticancer Agents

3. CHALLENGES OF DEVELOPING THE ABOVE STRATEGIES

4. RECENT PATENTS ISSUED IN THE AREA OF CSCS TARGETING

Cancer Stem Cell Targeting For Anticancer Therapy: Strategies and Challenges

Bentham Science Publishers

"This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The seventh volume of this series features 7 chapters that cover the following topics:
- Gut micriobiota and gastrointestinal cancer
- Dengue virus infections
- Synergistic antibiotic drug interactions
- Molecular modeling of antibacterial drugs
- Nucleic acid aptamers as anti-infective agents
- Fungal multidrug resistance
- The role of hydrogen sulfide in infections 
"


Frontiers in Anti-Infective Drug Discovery: Volume 7

Atta-ur-Rahman

Dr. M. lqbal Choudhary 

"Frontiers in Natural Product Chemistry is a book series devoted to important advances in natural product chemistry. The series features volumes that cover all aspects of research in the chemistry and biochemistry of naturally occurring compounds, including research on natural substances derived from plants, microbes and animals. Reviews of structure elucidation, biological activity, organic and experimental synthesis of natural products as well as developments of new methods are also included in the series.
 
Volume 10 of the series brings together 5 reviews on a variety of bioactive compounds.
 
An overview of cistus species growing in Sardinia: a source of bioactive compounds
Roles of natural abscisic acids in fruits during fruit development and under environmental stress
Progress in the research of naturally occurring biflavonoids: a look through
Plant metabolites for protecting human cells against radiation-associated damage: an integrative review
Chemical perspective and drawbacks in flavonoid estimation assays"


Frontiers in Natural Product Chemistry: Volume 10

Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The fifth volume of this series brings 5 reviews which cover the following topics: - Resistin: an irresistible therapeutic target for inflammatory diseases, allergy-related disorders, and cancer- Asthma in adults: evaluation, prevalence, and its clinical management- Nitrogen-containing heterocycles as anti-allergy agents- Experimental and clinical studies on the effects of nigella sativa and its constituents on allergic and immunological disorders- Aspirin desensitization/challenge in patients with cardiovascular diseases: current trends and advances Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field

Frontiers in Clinical Drug Research - Anti-Allergy Agents: Volume 5

"Topics in Anti-Cancer Research covers important advances on both experimental (preclinical) and clinical cancer research in drug development.  The book series offers readers an insight into current and future therapeutic approaches for the prevention of different types of cancers, synthesizing new anti-cancer agents, new patented compounds, targets and agents for cancer therapy as well as recent molecular and gene therapy research.
 
The comprehensive range of themes covered in each volume will be beneficial to clinicians, immunologists, and R&D experts looking for new anti-cancer targets and patents for the treatment of neoplasms, as well as varied approaches for cancer therapy.
 
The topics covered in the sixth volume of this series include:
- The role of microtubules for the cure of various untreated cancers
- Novel chemoimmunotherapy drug combinations & methods in clinical studies/trials
- Targeting polyunsaturated fatty acids (PUFAs) in the treatment of colorectal cancer
- Anti-cancer activity of natural and synthetic chalcones and their derivatives
- Recent advances in microRNA-based cancer therapeutics
- The role of inflammation in chemotherapy-induced neuromuscular effects
- Recent patents for treating heart failure due to inflammation, mitochondria and energy metabolism in cancer cachexia"


Topics in Anti-Cancer Research: Volume 6

Khurshid Zaman

"Frontiers in Drug Design and Discovery is a book series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists have contributed chapters focused on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. This book series should prove to be of interest to all pharmaceutical scientists who are involved in research in drug design and discovery and who wish to keep abreast of rapid and important developments in the field.
 
The ninth volume of this series brings together reviews covering topics related to the treatment of neoplasms, systems biology, respiratory diseases among others.
 
Topics included in this volume are:
 
-Prognostic biomarkers in prostate cancer
-Chemoresistance in cancer cells
-GPCRS in systems and synthetic biology
-Mechanisms of action of ribavirin in different diseases
-Carbon nanotubes and drug targets
-The role of phosphatase I inhibitors in Minkowski spaces
-Phosphodiesterase targeting for treating respiratory diseases
 "


Frontiers in Drug Design & Discovery: Volume 9

"Natural products continue to play a key role in drug development. A recent analysis of the drug market in the developed world revealed that 40% of total clinically approved drugs were either unmodified natural products or their semi-synthetic derivatives. This book series focuses on reviews of exciting new bioactive natural products that have huge potential as drugs. It highlights the everlasting importance of natural products in our lives. Each volume presents comprehensive reviews in cutting edge fields contributed by eminent scientists.
The first volume covers the following topics:
bioactive compounds from marine invertebrates
natural product derived drugs for immunological and inflammatory diseases
clinical trials of curcumin, camptothecin, astaxanthin, and biochanin
antibacterial and antifungal drugs from natural sources
natural products as anti-HIV medicines
 "


Natural Products in Clinical Trials: Volume 1

Shazia Anjum

"Frontiers in Clinical Drug Research - Anti-Cancer Agents - Volume 1 should prove to be a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field. The chapters in this volume have been written by leading experts from the field.
The contents of this book include new approaches to cancer therapy, treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors, targeting key signaling pathways in pediatric brain tumors, current status of cladribine in lymphoid and myeloid malignancies, natural anti-cancer products and the mechanisms of telomere and telomerase regulation in hematologic malignancies. 
The eBook series is essential to all scientists involved in clinical drug research who wish to keep abreast of rapid and important developments in the field. The readers will find these reviews valuable and  will certainly trigger further research in the pharmaceutical development of anti-cancer agents."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 1

"Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews  relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The ninth volume of the series features chapters covering the following topics:
- New research on the therapeutic intervention of cancer and cancer drug delivery
- Dabrafenib usage in melanoma therapy
- Targeting autophagy in cancer therapy
- Pro-apoptotic and anti-telomerase activity of naturally occurring compounds
- CDK inhibitors
- Oral nanostructure drug delivery for anti-cancer treatment
 "


Frontiers in Anti-Cancer Drug Discovery: Volume 9

"Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The seventh volume of the book features reviews on these topics:
 
· Essential oils and monoterpenes as potential anti-cancer agents
 
· Drug delivery systems and emerging immunotherapeutic strategies for the treatment of glioblastoma
 
· CTDNA in solid tumors
 
· Cholesterol treatments (including Pitavastatin) and their potential in cancer treatment"


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 7

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
 
 
The seventh volume of this series features reviews that cover the following topics related to the treatment of neurodegenerative diseases, epilepsy and stroke:
 
-Fatty Acid Amides as a New Potential Therapeutic Agent in Multiple Sclerosis
 
-Epileptic Seizures Detection Based on Non-Linear Characteristics Coupled with Machine Learning Techniques
 
-Hampering Essential Tremor Neurodegeneration in Essential Tremor: Present and Future Directions
 
-The Potential Therapeutic Role of the Melatoninergic System in Treatment of Epilepsy and Comorbid Depression
 
-Modeling Neurodegenerative Diseases Using Transgenic Model of Drosophila
 
-Genetic Basis in Stroke Treatment: Targets of Potent Inhibitors"


Your Cart

Topics in Anti-Cancer Research: Volume 8

$ 89.00

Description of Topics in Anti-Cancer Research: Volume 8

Additional Information

About the authors

Atta-ur-Rahman

Frontiers in Anti-Infective Drug Discovery: Volume 7

Frontiers in Natural Product Chemistry: Volume 10

Frontiers in Clinical Drug Research - Anti-Allergy Agents: Volume 5

Topics in Anti-Cancer Research: Volume 6

Frontiers in Drug Design & Discovery: Volume 9

Natural Products in Clinical Trials: Volume 1

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 1

Frontiers in Anti-Cancer Drug Discovery: Volume 9

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 7

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 7

Atta-ur-Rahman